Peripheral neuropathy decisions — 2025

The Board granted the Veteran's claim for an allowance for an automobile or other conveyance, and adaptive equipment due to permanent loss of use of one hand resulting from service-connected disabilities.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on aid and attendance, finding that he does not meet the criteria due to his service-connected disabilities.

The Board denied earlier effective dates for service connection and ratings for various diabetic conditions, as the earliest possible date under the PACT Act was August 10, 2022.

The Board remands the claims for service connection for right and left lower extremity peripheral neuropathy, to include as due to exposure to an herbicidal agent, for additional development.

The Board granted an initial disability rating of 40 percent for lumbosacral strain with intervertebral disc syndrome and earlier effective dates for several service-connected conditions, but denied service connection for bilateral hearing loss and tinnitus.

The Board granted initial evaluations of 30 percent for the left upper extremity and 40 percent for both the right (major) and left lower extremities, but denied earlier effective dates for service connection.

The Board denied the veteran's claims for earlier effective dates, higher ratings for PTSD, and service connection for various conditions, while remanding several service connection claims.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board remands the Veteran's claims for a retrospective opinion to address the severity of his peripheral neuropathy prior to May 12, 2014.

The Board granted service connection for intervertebral disc syndrome of the neck and left upper extremity neuropathy, finding a nexus to an in-service motor vehicle accident.

The Board granted a 100 percent rating for coronary artery disease from August 3, 2021, and an initial rating of 60 percent for diabetic nephropathy. The claims for increased ratings for diabetes mellitus type II, left lower extremity diabetic peripheral neuropathy (sciatic nerve), right lower extremity diabetic peripheral neuropathy (sciatic nerve), and femoral nerves were denied.

The Board denied service connection for obstructive sleep apnea, peripheral neuropathy of both upper and lower extremities, and bladder cancer as the evidence did not support a finding that these conditions were related to the Veteran's active military service or any service-connected disability.

The Board remands the claims for further development and consideration of additional evidence.

The Board remands the claim for service connection for diabetes mellitus, type II, to obtain an addendum opinion addressing whether the Veteran's service-connected disabilities caused or aggravated his obesity and whether that obesity was a substantial factor in causing diabetes.

The Board remands the claims for service connection for left and right inclusion body myositis to obtain an addendum medical opinion addressing the Veteran's contentions, including research articles submitted in May 2024.

The Board dismissed the claims for service connection for various conditions due to untimeliness of the Veteran's VA Form 10182 or as moot, and remanded the claim for diabetes mellitus type II.

The Board denied an effective date prior to March 31, 2015 for the grant of service connection for right lower extremity neuropathy.

The Board denied an initial rating in excess of 50 percent prior to April 13, 2023 and in excess of 70 percent thereafter for trauma and stress related disorder, anxiety disorder, and insomnia disorder. The Board also remanded the claims for initial compensable ratings for right foot idiopathic peripheral neuropathy and left foot idiopathic peripheral neuropathy.

The Board denied service connection for residuals of a TBI, bilateral shin splints, right ankle disorder, right knee disorder, left knee disorder, and an initial rating in excess of 20 percent for right hand neuropathy.

The Board remands the claims for increased ratings and special monthly compensation, as well as a TDIU, due to insufficient medical evidence regarding the severity of peripheral neuropathy in both upper and lower extremities.